Stryker Corporation  

(Public, NYSE:SYK)   Watch this stock  
Find more results for Floyd Hand
-0.67 (-0.72%)
Jan 23 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 92.60 - 93.71
52 week 75.78 - 98.24
Open 93.24
Vol / Avg. 961,450.00/1.40M
Mkt cap 35.07B
P/E 55.30
Div/yield 0.34/1.49
EPS 1.68
Shares 378.00M
Beta 0.96
Inst. own 73%
Apr 20, 2015
Stryker Annual Shareholder Meeting (Estimated) Add to calendar
Jan 27, 2015
Q4 2014 Stryker Corp Earnings Call - 4:30PM EST - Add to calendar
Jan 27, 2015
Q4 2014 Stryker Corp Earnings Release - 4:00PM EST - Add to calendar
Jan 14, 2015
Stryker Corp at JPMorgan Healthcare Conference - Q&A
Jan 14, 2015
Stryker Corp at JPMorgan Healthcare Conference
Nov 18, 2014
Stryker Corp at Stifel Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 2.39% 11.15%
Operating margin 18.84% 13.92%
EBITD margin - 25.77%
Return on average assets 1.32% 6.95%
Return on average equity 2.59% 11.40%
Employees 25,000 -
CDP Score - 53 E


2825 Airview Boulevard
United States - Map
+1-269-3852600 (Phone)
+1-269-3851062 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


Stryker Corporation is a medical technology company. The Company�s products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties. The Company�s products are marketed directly to doctors, hospitals and other healthcare facilities in the United States. The Company has three reportable business segments: Reconstructive, MedSurg, and Neurotechnology and Spine. Reconstructive products consist of implants used in hip and knee joint replacements and trauma and extremities surgeries, MedSurg products include surgical equipment and surgical navigation systems and other medical device products used in medical specialties and Neurotechnology and Spine products include both neurosurgical and neurovascular devices.

Officers and directors

Kevin A. Lobo Chairman of the Board, President, Chief Executive Officer
Age: 49
Bio & Compensation  - Reuters
William R. Jellison Chief Financial Officer, Vice President
Age: 56
Bio & Compensation  - Reuters
Lonny J. Carpenter Group President - Global Quality and Operations
Age: 52
Bio & Compensation  - Reuters
David K. Floyd Group President - Orthopaedics
Age: 53
Bio & Compensation  - Reuters
Timothy J. Scannell Group President - MedSurg and Neurotechnology
Age: 49
Bio & Compensation  - Reuters
Ramesh Subrahmanian Group President - International
Age: 52
Bio & Compensation  - Reuters
Scott P. Bruder M.D., Ph.D. Vice President, Chief Medical and Scientific Officer
Age: 51
Bio & Compensation  - Reuters
Steven P. Benscoter Vice President - Human Resources
Age: 46
Bio & Compensation  - Reuters
Katherine Ann Owen Vice President - Strategy and Investor Relations
Age: 43
Bio & Compensation  - Reuters
Dean H. Bergy Vice President, Corporate Secretary
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance